Therapeutics: News and Research on Glycemic Control

MeSH tree: E02.491

Diabetes outcomes worsen after insurance loss, study finds

Losing health insurance can quickly worsen health for people with diabetes as patients struggle to control the disease after coverage is interrupted, according to new research from Oregon Health & Science University.

Understanding GLP-1 signaling: A path to better therapies

About one in eight U.S. adults are currently taking a GLP-1 drug such as Ozempic, Wegovy, or Zepbound to treat diabetes, obesity, or other conditions, according to a KFF Health Tracking poll. But many suffer from significant ...

page 1 from 2